Abstract
Earlier studies have revealed a relationship between the development of myringosclerosis and oxygen-derived free radicals. The latter can be blocked by the anti-inflammatory drug fenspiride. The present study was undertaken to test the ability of fenspiride to prevent myringosclerosis from developing during healing of the tympanic membrane. Myringotomized rats were treated with either topical applications or intraperitoneal injections of fenspiride for 12 days, after which the tympanic membranes were examined by otomicroscopy and studied histologically by light microscopy. Topically applied fenspiride was found to inhibit the development of sclerotic lesions, whereas intraperitoneal injections were ineffective.
Similar content being viewed by others
References
Albiin N, Hellström S, Salén B, Stenfors L-E, Wirell S (1985) The vascular supply of the rat tympanic membrane. Anat Rec 212:17–22
Carre P, Pipy B, Pinelli E, Forgue MF, Beraud M, Didier A, Leophonte P (1991) In vitro effects of fenspiride on the production of free oxygen radicals, prostaglandins and leukotrienes by guinea-pig alveolar macrophages. Eur Respir Rev 1: 79–85
Cuénant G (1988) Efficacy of Pneumorel 80 mg (fenspiride) in the treatment of chronic sinusitis. Rhinol Suppl 4:21–29
Cunha FQ, Boukili MA, Bragda da Motto JI, Vargaftig BB, Ferreira SH (1993) Blockade by fenspiride of endotoxin-induced neutrophil migration in the rat. Eur J Pharmacol 238:47–52
Evrard Y, Kato G, Bodinier MC, Chapelain B (1991) Fenspiride and inflammation in experimental pharmacology. Eur Respir Rev 1:93–100
Fraysse B, Calvet H, Fayre P, Shutz D (1988) Value of fenspiride (Pneumorel 80 mg) in the preoperative treatment of chronic open tympanum otitis. Rhinol Suppl 4:31–42
Hellström S, Spandow O (1994) Exogenous heparin, topically administered, aids the remodelling of connective tissue in the healing of experimental tympanic membrane perforations. ORL J Otorhinolaryngol Relat Spec 56:45–50
Hellström S, Jung TTK, Magnuson K, Mattsson C, Johansson U, Crambes O (1996). Fenspiride reduces vascular leakage and inflammation in experimental serous otitis media. In: Lim DJ, Bluestone CD, Casselbrandt M, Klein JO, Ogra PL (eds) Recent advances in otitis media. Decker, Hamilton, Ontario, pp 522–524
Kukreja RC, Kontos HA, Hess ML, Ellis EF (1986) PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH. Circ Res 59:612–619
Laurent C, Hellström S, Fellenius E (1988) Hyaluronan improves the healing of experimental tympanic membrane perforations. Arch Otolaryngol Head Neck Surg 114:1435–1441
Lonchampt M, Evrard Y, Duhault J (1988) Recent data on the pharmacology of fenspiride. Rhinol Suppl 4:59–66
Mattsson C, Magnuson K, Hellström S (1995) An increased oxygen concentration causes myringosclerosis in traumatized tympanic membranes — an experimental study. Ann Otol Rhinol Laryngol 104:625–632
Mattsson C, Marklund SL, Hellström S (1997) Application of oxygen free radical scavengers diminishes the occurrence of myringosclerosis. Ann Otol Rhinol Laryngol 106:513–518
Sallebert L, Schutz D (1988) Value of Pneumorel 80 mg in the treatment of chronic otitis in adults. Rhinol Suppl 4:43–58
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mattsson, C., Hellström, S. Inhibition of the development of myringosclerosis by local administration of fenspiride, an anti-inflammatory drug. Eur Arch Otorhinolaryngol 254, 425–429 (1997). https://doi.org/10.1007/BF02439973
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02439973